// App-Quantinova.ai

TCT-59 : Overlapping Bioresorbable Coronary Devices: Immediate Results and 6-month Follow-up of the REPARA Registry

Researchers

Presenter

  • Felipe Hernandez

Principal Investigators

  • Luis Gaviria

  • Joan Bassaganyas

  • Juan Alonso Briales

  • Juan Francisco Oteo Dominguez

  • Pedro Martinez-Romero

  • Leire Andraka

  • Antonio Serra

  • MARCOSTOMAS RODRIGUEZ

Medical Centers

  • Unknown, Barcelona, Spain

  • Hospital Clinico, Valladolid, Spain

  • Hospital Ramon y Cajal, Madrid, Spain

  • Hospital Santo Antonio, Porto, Portugal

  • Hospital Universitario de Canarias, Santa Cruz De Tenerife, Spain

  • Valencia, Spain

  • Hospital Universitario del Mar, Barcelona, Spain

  • Hospital Universitario De Salamanca-IBSAL, Salamanca, Spain

  • Hospital de Basurto, Basurto, Spain

  • Unknown, Valencia, Spain

  • Hospital de Braga, Braga, Portugal

  • Unknown, Donostia, Spain

  • Hospital Universitario Cruces, Vizcaya, Spain

  • Hospital de Torrejon, Madrid, Spain

  • Hospital Santa Creu i Sant Pau, Barcelona, Spain

  • Hospital Universitario de Canarias, Santa Cruz De Tenerife, Spain

  • de Octubre, Madrid,Spain

  • H. Universitario Miguel Servet, Zaragoza, Spain

  • hospital de girona, olot, Spain

  • Unknown, Madrid, Spain

  • Public Hospital, Palma de Mallorca, Spain

Locations

  • Spain

  • Portugal

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved